Circum-Psoas Blocks Versus Combined Lumbar and Sacral Plexus Blocks in Hip Fracture Surgery
Hip Fractures
About this trial
This is an interventional prevention trial for Hip Fractures focused on measuring circum-psoas blocks, lumbar plexus block, sacral plexus block, hip fracture surgery
Eligibility Criteria
Inclusion Criteria: Patient acceptance. BMI ≤ 30 kg/m2 ASA I-III. First unilateral surgery for hip fracture including femoral neck, intertrochanteric or subtrochanteric fracture. Patient with planned hip fracture surgery within 24-72 hours under general anesthesia. Exclusion Criteria: Multiple trauma, multiple fractures, or pathological fractures Prosthetic fracture or usage of bone-cement fixation in the surgery. Scheduled for bilateral hip fracture surgery. Pre-existing neurological deficit in the lower extremity Contraindication for peripheral nerve block (infection at the site of needle insertion, coagulopathy, allergy to local anesthetics used) History of chronic pain and taking analgesics History of cognitive dysfunction or mental illness
Sites / Locations
- Shereen E Abd EllatifRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Placebo Comparator
Active Comparator
Active Comparator
control group
LSP group (lumbar and sacral plexus block)
CP group (circum-psoas block)
patients will be operated on under general anesthesia
patients will receive ultrasound-guided combined lumbar and sacral plexus blocks with 40 ml of 0.25% of bupivacaine.
patients will receive ultrasound-guided circum-psoas blocks with 40 ml of 0.25% of bupivacaine.